Simpson Thacher represented Centerbridge Partners in the acquisition by one of its affiliates of a controlling interest in Remedi SeniorCare Holding Corporation for an aggregate capital commitment of up to $300 million.  The investment will be used to support the continued development and deployment of Remedi’s automated medication administration technology, as well as acquisitions and greenfield start-up pharmacies in new markets across the United States.

Remedi SeniorCare, based in Baltimore, is one of the nation’s largest institutional pharmacy companies. Through its patented technologies and web-based solutions, Remedi SeniorCare enables long-term care facility operators and providers to deliver medication management and other services in skilled nursing and assisted living facilities.

The Simpson Thacher team includes:  Caroline Gottschalk, Daniel Tseng and Gibbs Fryer (M&A); Greg Grogan and Craig Katerberg (Executive Compensation and Employee Benefits); Gary Mandel, Jonathan Goldstein and Danny Salinas (Tax); Jonathan Karen and Nicole Washington (Private Funds); Marissa Wesely (Credit); Lori Lesser and Jodie Sopher Pimentel (Intellectual Property); Adeeb Fadil (Environmental); and Joseph Tringali and Michael Naughton (Antitrust).